It is reasonable to speculate that as S100A12 levels rise during the development of PAD, its binding receptors such as TLR-4 and RAGE may become saturated, which leads to saturation of the inflammatory response it mediates. This evidence concerns the gene TLR4 and peripheral arterial disease.